IN8BIO, INC. (INAB)
2025-06-30 | ||||
|---|---|---|---|---|
| Research and development | 2,487 | |||
| General and administrative | 2,714 | |||
| Total operating expenses | 5,201 | |||
| Interest income | 107 | |||
| Loss from operations | -5,094 | |||
| Net loss | -5,094 | |||
| Net loss per share - basic | -1.24 | |||
| Net loss per share - diluted | -1.24 | |||
| Weighted-average number of shares used in computing net loss per common share, basic | 4,119,153 | |||
| Weighted-average number of shares used in computing net loss per common share, diluted | 4,119,153 | |||